Chemins
This article was originally published in The Tan Sheet
Executive Summary
Dietary supplement manufacturer and its founder and president entered not guilty pleas in Denver federal court Nov. 9 to charges of product misbranding, conspiracy, making false statements, aiding and abetting, and obstructing FDA's investigation into the firm's alleged use of pharmaceutical-grade ephedrine and caffeine in its products. No trial date has been set. A grand jury on Oct. 21 returned a 14-count indictment against the company and exec James Cameron related to the manufacture of Formula One supplements with ma huang and kola nut (1"The Tan Sheet" Oct. 25, p. 5)